Skye Bioscience SKYE
NASDAQ SKYE
$1.61 +0.02 (+1.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Change in Receivables (2013)

Updated

Skye Bioscience (SKYE) recorded Change in Receivables of $10,087 in Q1 2014.

Analysis

Skye Bioscience (SKYE) Change in Receivables (2013) Analysis & Trends

On a TTM basis, Skye Bioscience's Change in Receivables came in at $13,793 as of Apr 30, 2014; for FY2013, it was $18,432, up 166.9% from FY2012.

  • Across earlier years, Change in Receivables came in at $6,906 in FY2012.
  • Quarterly Change in Receivables has ranged from -$3,412 in Q3 2013 to $14,726 in Q1 2013 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Skye Bioscience 7.07 Mn 7.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2013 -3,328.00
Jul 31, 2013 -3,412.00
Apr 30, 2013 10,446.00
Jan 31, 2013 14,726.00
API Access

Skye Bioscience Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=SKYE&period=max&api_key=YOUR_API_KEY